Research News From October 23, 2005
advertisement
- Nicotinamide protected first-phase insulin response (FPIR) and prevented clinical disease in first-degree relatives of type-1 diabetics.
- Boost for type 1 vaccine research.
- Enteroviruses: New findings on the role of enteroviruses in type 1 diabetes.
- Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.
- MMR Vaccine is Safe, International Team Affirms.